Advertisement

Journal of Cancer Research and Clinical Oncology

, Volume 142, Issue 12, pp 2497–2502 | Cite as

Detection of human papillomavirus-16 DNA in archived clinical samples of breast and lung cancer patients from North Pakistan

  • Naureen Ehsan Ilahi
  • Sobia Anwar
  • Mamoona Noreen
  • Shoaib Naiyar Hashmi
  • Sheeba MuradEmail author
Original Article – Cancer Research

Abstract

Purpose

Over the past few decades, human papillomavirus (HPV) has been recorded as a key player in the development of various genital cancers, most notably cervical cancer. It has also been associated with some non-genital cancers. A subset of oropharyngeal cancers are known to be caused by HPV. Its aetiological involvement has been suggested for breast and lung cancer as well. However, reports regarding the HPV DNA detection vary widely from different parts of the world. Due to scarcity of local data in this regard, the current study aimed at retrospective detection of HPV presence in the archival samples of breast and lung cancer patients from north part of the country.

Methods

A total of 55 formalin-fixed paraffin-embedded tissue sections of invasive ductal carcinoma of breast (n = 46) and lung (n = 9) were collected for this study. Genotyping for HPV16 and 18 was carried out through PCR.

Results

HPV16 DNA was found in both breast and lung carcinoma samples with the prevalence rate of 17 and 11 %, respectively. An interesting association was found between ER/PR (Oestrogen/Progesterone receptor) and HER2/Neu (Human epidermal growth factor receptor-2) positivity with HPV occurrence in breast tumours.

Conclusion

Current study shows the presence of HPV16 DNA in archived clinical biopsy sections from breast and lung cancers (17, 11 %), respectively. A positive correlation of HPV16 presence was found with ER/PR and HER2-positive breast cancers. These initial findings warrant further investigation in order to determine HPV prevalence and aetiological role in local cancers, especially in ER/PR/HER2-positive breast cancers on a larger scale.

Keywords

Human papillomavirus Breast cancer Lung cancer 

Notes

Acknowledgments

We are grateful to the Higher Education Commission (HEC) of Pakistan, recurring budget of Atta-ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences and Technology (NUST) and Schlumberger Foundation for their kind support.

Compliance with ethical standards

Conflict of interest

No conflict of interest is declared by the authors.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

References

  1. Aguayo F et al (2010) Human papillomavirus-16 presence and physical status in lung carcinomas from Asia. Infect Agent Cancer 5:20. doi: 10.1186/1750-9378-5-20 CrossRefPubMedPubMedCentralGoogle Scholar
  2. Ahmed S, Jafarey NA (1995) Association of herpes simplex virus type-I and human papilloma virus with carcinoma of the oral cavity and oropharynx. J Environ Pathol Toxicol Oncol 14:193–196PubMedGoogle Scholar
  3. Baay MF et al (1996) Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol 34:745–747PubMedPubMedCentralGoogle Scholar
  4. Baig S et al (2012) Human papilloma virus and oral lesions in gutka eating subjects in Karachi. J Coll Physicians Surg Pak 22:135–138. doi:02.2012/JCPSP.135138PubMedGoogle Scholar
  5. Band V, Zajchowski D, Kulesa V, Sager R (1990) Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proc Natl Acad Sci USA 87:463–467CrossRefPubMedPubMedCentralGoogle Scholar
  6. Brake T, Lambert PF (2005) Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model. Proc Natl Acad Sci USA 102:2490–2495. doi: 10.1073/pnas.0409883102 CrossRefPubMedPubMedCentralGoogle Scholar
  7. Bratthauer GL, Tavassoli FA, O’Leary TJ (1992) Etiology of breast carcinoma: no apparent role for papillomavirus types 6/11/16/18. Pathol Res Pract 188:384–386. doi: 10.1016/S0344-0338(11)81229-X CrossRefPubMedGoogle Scholar
  8. Bromberg-White JL, Meyers C (2003) Comparison of the basal and glucocorticoid-inducible activities of the upstream regulatory regions of HPV18 and HPV31 in multiple epithelial cell lines. Virology 306:197–202. doi: 10.1016/S0042-6822(02)00041-7 CrossRefPubMedGoogle Scholar
  9. Castillo A et al (2011) Human papillomavirus in upper digestive tract tumors from three countries. World J Gastroenterol 17:5295–5304. doi: 10.3748/wjg.v17.i48.5295 CrossRefPubMedPubMedCentralGoogle Scholar
  10. Cobos C et al (2014) The role of human papilloma virus (HPV) infection in non-anogenital cancer and the promise of immunotherapy: a review. Int Rev Immunol 33:383–401. doi: 10.3109/08830185.2014.911857 CrossRefPubMedGoogle Scholar
  11. de Cremoux P, Thioux M, Lebigot I, Sigal-Zafrani B, Salmon R, Sastre-Garau X (2008) No evidence of human papillomavirus DNA sequences in invasive breast carcinoma. Breast Cancer Res Treat 109:55–58. doi: 10.1007/s10549-007-9626-4 CrossRefPubMedGoogle Scholar
  12. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ (1995) The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76(Pt 4):1057–1062. doi: 10.1099/0022-1317-76-4-1057 CrossRefPubMedGoogle Scholar
  13. Forman D et al (2012) Global burden of human papillomavirus and related diseases. Vaccine 30(Suppl 5):F12–F23. doi: 10.1016/j.vaccine.2012.07.055 CrossRefPubMedGoogle Scholar
  14. Galvan A, Noci S, Taverna F, Lombardo C, Franceschi S, Pastorino U, Dragani TA (2012) Testing of human papillomavirus in lung cancer and non-tumor lung tissue. BMC Cancer 12:512. doi: 10.1186/1471-2407-12-512 CrossRefPubMedPubMedCentralGoogle Scholar
  15. Gillison ML, Chaturvedi AK, Lowy DR (2008) HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 113:3036–3046. doi: 10.1002/cncr.23764 CrossRefPubMedGoogle Scholar
  16. Gopalkrishna V, Singh UR, Sodhani P, Sharma JK, Hedau ST, Mandal AK, Das BC (1996) Absence of human papillomavirus DNA in breast cancer as revealed by polymerase chain reaction. Breast Cancer Res Treat 39:197–202CrossRefPubMedGoogle Scholar
  17. Gorgoulis VG et al (1999) Human papilloma virus (HPV) is possibly involved in laryngeal but not in lung carcinogenesis. Hum Pathol 30:274–283CrossRefPubMedGoogle Scholar
  18. Haghshenas MR, Mousavi T, Moosazadeh M, Afshari M (2016) Human papillomavirus and breast cancer in Iran: a meta- analysis. Iran J Basic Med Sci 19:231–237PubMedPubMedCentralGoogle Scholar
  19. Hedau S et al (2011) Breast cancer and human papillomavirus infection: no evidence of HPV etiology of breast cancer in Indian women. BMC Cancer 11:27. doi: 10.1186/1471-2407-11-27 CrossRefPubMedPubMedCentralGoogle Scholar
  20. Heng B et al (2009) Human papilloma virus is associated with breast cancer. Br J Cancer 101:1345–1350CrossRefPubMedPubMedCentralGoogle Scholar
  21. Herrera-Romano L et al (2012) Absence of human papillomavirus sequences in epithelial breast cancer in a Mexican female population. Med Oncol 29:1515–1517. doi: 10.1007/s12032-011-0059-x CrossRefPubMedGoogle Scholar
  22. Huang H, Hu XF, Zhao FH, Garland SM, Bhatla N, Qiao YL (2015) Estimation of cancer burden attributable to infection in Asia. J Epidemiol 25:626–638. doi: 10.2188/jea.JE20140215 CrossRefPubMedPubMedCentralGoogle Scholar
  23. Ilahi NE, Hashmi NS, Anwar S, Murad S (2016) Retrospective analysis of HPV 16/18 related disease burden using archival clinical samples. J Cancer Res Clin Oncol. doi: 10.1007/s00432-016-2227-z Google Scholar
  24. Iwakawa R, Kohno T, Enari M, Kiyono T, Yokota J (2010) Prevalence of human papillomavirus 16/18/33 infection and p53 mutation in lung adenocarcinoma. Cancer Sci 101:1891–1896CrossRefPubMedGoogle Scholar
  25. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90. doi: 10.3322/caac.20107 CrossRefPubMedGoogle Scholar
  26. Khan NA et al (2008) Human papillomavirus detected in female breast carcinomas in Japan. Br J Cancer 99(408):414. doi: 10.1038/sj.bjc.6604502 Google Scholar
  27. Klein F, Amin Kotb WF, Petersen I (2009) Incidence of human papilloma virus in lung cancer. Lung Cancer 65:13–18. doi: 10.1016/j.lungcan.2008.10.003 CrossRefPubMedGoogle Scholar
  28. Koshiol J et al (2011) Assessment of human papillomavirus in lung tumor tissue. J Natl Cancer Inst 103:501–507CrossRefPubMedPubMedCentralGoogle Scholar
  29. Lawson JS, Gunzburg WH, Whitaker NJ (2006) Viruses and human breast cancer. Future Microbiol 1:33–51. doi: 10.2217/17460913.1.1.33 CrossRefPubMedGoogle Scholar
  30. Lawson J, Glenn W, Heng B, Ye Y, Tran B, Lutze-Mann L, Whitaker N (2009) Koilocytes indicate a role for human papilloma virus in breast cancer. Br J Cancer 101:1351–1356CrossRefPubMedPubMedCentralGoogle Scholar
  31. Lawson JS et al (2015) Human papilloma viruses and breast cancer. Front Oncol 5:277. doi: 10.3389/fonc.2015.00277 CrossRefPubMedPubMedCentralGoogle Scholar
  32. Li N, Bi X, Zhang Y, Zhao P, Zheng T, Dai M (2011) Human papillomavirus infection and sporadic breast carcinoma risk: a meta-analysis. Breast Cancer Res Treat 126:515–520. doi: 10.1007/s10549-010-1128-0 CrossRefPubMedGoogle Scholar
  33. Lim W-T, Chuah KL, Leong SS, Tan EH, Toh CK (2009) Assessment of human papillomavirus and Epstein-Barr virus in lung adenocarcinoma. Oncol Rep 21:971–975CrossRefPubMedGoogle Scholar
  34. Mou X et al (2011) Low prevalence of human papillomavirus (HPV) in Chinese patients with breast cancer. J Int Med Res 39:1636–1644CrossRefPubMedGoogle Scholar
  35. Pater MM, Mittal R, Pater A (1994) Role of steroid hormones in potentiating transformation of cervical cells by human papillomaviruses. Trends Microbiol 2:229–234CrossRefPubMedGoogle Scholar
  36. Prabhu PR, Jayalekshmi D, Pillai MR (2012) Lung cancer and human papilloma viruses (HPVs): examining the molecular evidence. J Oncol 2012:1–10. doi:  10.1155/2012/750270 CrossRefGoogle Scholar
  37. Roglić M, Jukić S, Damjanov I (1974) Cytology of the solitary papilloma of the bronchus. Acta Cytol 19:11–13Google Scholar
  38. Rubel L, Reynolds R (1978) Cytologic description of squamous cell papilloma of the respiratory tract. Acta Cytol 23:227–231Google Scholar
  39. Saiki RK et al (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487–491CrossRefPubMedGoogle Scholar
  40. Santarelli GD, Derkay CS (2016) HPV vaccines for treatment and prevention of recurrent respiratory papillomatosis. Curr Otorhinolaryngol Rep 4:85–89. doi: 10.1007/s40136-016-0119-z CrossRefGoogle Scholar
  41. Sturgis EM, Cinciripini PM (2007) Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 110:1429–1435. doi: 10.1002/cncr.22963 CrossRefPubMedGoogle Scholar
  42. Syrjänen K (1979) Condylomatous changes in neoplastic bronchial epithelium. Respiration 38:299–304CrossRefPubMedGoogle Scholar
  43. Wang T et al (2012) The role of human papillomavirus infection in breast cancer. Med Oncol 29:48–55. doi: 10.1007/s12032-010-9812-9 CrossRefPubMedGoogle Scholar
  44. Wazer DE, Liu XL, Chu Q, Gao Q, Band V (1995) Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7. Proc Natl Acad Sci USA 92:3687–3691CrossRefPubMedPubMedCentralGoogle Scholar
  45. Wrede D, Luqmani YA, Coombes RC, Vousden KH (1992) Absence of HPV 16 and 18 DNA in breast cancer. Br J Cancer 65:891–894CrossRefPubMedPubMedCentralGoogle Scholar
  46. Yu Y et al (1999) HPV33 DNA in premalignant and malignant breast lesions in Chinese and Japanese populations. Anticancer Res 19:5057–5061PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Naureen Ehsan Ilahi
    • 1
  • Sobia Anwar
    • 1
  • Mamoona Noreen
    • 1
  • Shoaib Naiyar Hashmi
    • 2
  • Sheeba Murad
    • 1
    • 3
    Email author
  1. 1.Atta-ur-Rahman School of Applied BiosciencesNational University of Science’s and TechnologyIslamabadPakistan
  2. 2.Armed Forces Institute of PathologyRawalpindiPakistan
  3. 3.Institute for Infection and ImmunitySt George’s University of LondonLondonUK

Personalised recommendations